ABIO Shares Outstanding History
Below is a table of the ABIO shares outstanding history going back to 9/4/2015:

Date ABIO Shares Outstanding
9/4/20150.01B
11/10/20159.05M
3/15/20169.06M
5/9/20169.07M
8/5/20169.07M
11/10/20169.08M
3/17/20179.13M
5/11/20179.24M
7/31/201711.75M
11/7/201711.75M
3/19/201813.91M
5/4/201813.92M
8/7/201813.92M
11/12/201813.92M

Also see: ABIO Market Cap History
and ABIO YTD Return
ABIO Historical Shares Outstanding:
+14.53% CAGR
ABIO Historical Shares Outstanding: +14.53% CAGR

Mouse over chart for data details
9/4/2015 ...11/12/2018
ARCA biopharma is a biopharmaceutical company focused on developing genetically-targeted therapies for cardiovascular diseases. Co.'s key product candidate, Gencaro™ (bucindolol hydrochloride), is an investigational pharmacological beta-blocker and mild vasodilator that Co. is developing for the potential treatment of patients with chronic heart failure with reduced left ventricular ejection fraction, who also have atrial fibrillation (AF), or at risk of developing AF. Co. also has pharmacogenetic and other patent rights to drug candidates that have potential indications in cardiovascular disease, oncology and other therapeutic areas. We show 14 historical shares outstanding datapoints in our coverage of ABIO's shares outstanding history.

Understanding the changing numbers of ABIO shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ABIO versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ABIO by allowing them to research ABIO shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ABIO:
ABIO SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ARCA biopharma (ABIO) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ABMD Shares Outstanding History
ABT Shares Outstanding History
ACAD Shares Outstanding History
ACER Shares Outstanding History
ACET Shares Outstanding History
ACHC Shares Outstanding History
ACHN Shares Outstanding History
ACHV Shares Outstanding History
ACOR Shares Outstanding History
ACRS Shares Outstanding History
More Healthcare companies »

 

ABIO Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2018, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.